Reprimo as a potential biomarker for early detection in gastric cancer - Wikidata - awgldk - TriplyDB

Reprimo as a potential biomarker for early detection in gastric cancer

Reprimo as a potential biomarker for early detection in gastric cancer

http://www.wikidata.org/entity/Q28295727

about

Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis Emerging blood-based biomarkers for detection of gastric cancer Challenges of deciphering gastric cancer heterogeneity Noncoding Genomics in Gastric Cancer and the Gastric Precancerous Cascade: Pathogenesis and Biomarkers Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric Cancer Whole blood DNA aberrant methylation in pancreatic adenocarcinoma shows association with the course of the disease: a pilot study The current situation for gastric cancer in Chile p42.3 gene expression in gastric cancer cell and its protein regulatory network analysis Reprimo tissue-specific expression pattern is conserved between zebrafish and human.Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsies Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer.DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer Epigenetic inactivation of heparan sulfate (glucosamine) 3-O-sulfotransferase 2 in lung cancer and its role in tumorigenesis.Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells.DNA Methylation Predicts Progression of Human Gastric Lesions Methylation-Sensitive Melt Curve Analysis of the Reprimo Gene Methylation in Gastric Cancer.DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer.Implication of Reprimo and hMLH1 gene methylation in early diagnosis of gastric carcinoma Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line.The relationship between promoter methylation of p16 gene and bladder cancer risk: a meta-analysis.DNA and histone methylation in gastric carcinogenesis CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer.Virulence of infecting Helicobacter pylori strains and intensity of mononuclear cell infiltration are associated with levels of DNA hypermethylation in gastric mucosae.Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system.Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.Epigenetic mechanisms in gastric cancer.Helicobacter pylori-Induced Chronic Gastritis and Assessing Risks for Gastric Cancer.Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer.Novel biomarkers for the identification and targeted therapy of gastric cancer.Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer.A modified bisulfite conversion method for the detection of DNA methylation.Epigenetic regulation and anti-tumorigenic effects of SH2-containing protein tyrosine phosphatase 1 (SHP1) in human gastric cancer cells.Epigenetic regulation in gallbladder cancer: Promoter methylation profiling as emergent novel biomarkers.tp53-dependent G2 arrest mediator candidate gene, Reprimo, is down-regulated by promoter hypermethylation in pediatric acute myeloid leukemia.Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer How to stomach an epigenetic insult: the gastric cancer epigenome.Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer.

P2860

Q26775839-25DBD9D1-C4BA-4FA6-B991-3C2329EE3341 Q26778026-F8BF476F-C4A2-4647-AC44-2CAC9E38E67D Q26784448-3DD3CA5B-0E1E-417D-9B18-171CDD63653D Q26785700-0217D36A-843A-4CE7-9840-FC1157A8495F Q28261753-BED43EAA-40D4-4CCA-B550-E4F4A7416F42 Q28729757-CE5C8BFA-2371-4C95-8110-0CF8A28DCE66 Q30238920-79125ACE-D0F0-4D61-AD7B-3FAB962F2311 Q30424625-FE1B925C-D586-4F9A-9871-4EFFF8F70085 Q33745928-35BF2F12-E848-4911-9A7D-4725C68D2654 Q33888849-5D51755F-84CF-4C97-9BC0-8D3B2CCC16AB Q34047716-2CA27F6C-0C4E-4EF3-8366-3CEDD0EB4B15 Q34478077-4A07D766-05BC-46F0-8BE0-029279A7AE74 Q34603514-AEBCD346-67F8-4119-8583-C4E52839493B Q34609329-E4D6891D-B5BF-4735-98F7-0CBFED982F1B Q35050525-4F1EDBF1-FCB4-4C0D-92EF-7C2FE3933627 Q35593032-91E4A3AC-B7EB-4C69-A2BD-F76B6FBA56C5 Q35691776-E086889C-E34E-466E-9C77-ED7E89609C33 Q36117983-6ABEDDFE-30DF-4AD4-BB0A-3A1A3853594F Q36228641-08EE4F93-2414-4051-A666-ED563F3B4BCB Q36300261-D46DA328-FB9C-4786-9400-A6DD15145AC1 Q36464745-0CC8B78C-8ABF-406E-879C-5504F2EC7724 Q36489832-3F128524-0635-4AA4-99DF-E526960EFEAE Q36492827-AA2FC07A-69F6-4A9F-848E-0F821681CE4D Q36654458-346EE82B-3811-4FD7-93DA-2272435D2059 Q37403610-BB9DF4A5-1573-4C3E-9C7A-3D907FDF6B4F Q37590751-F91815F3-2775-4003-AC1E-4F8E51E01B15 Q37645061-34234A9E-A2D6-47FC-899D-B5AA6ED11491 Q37824622-A0B34078-1A53-4563-8357-2BB9B0FAC3D2 Q38018086-668114BC-6A62-448C-9EBA-1D584C57C0FC Q38132130-2DC6B829-76B3-48A7-99AB-954C0662ED22 Q38391277-4A3A478D-A018-4DFA-BB40-404A4BDD74FF Q38556435-4824677C-A5A6-4014-8B66-BEF23B3CC612 Q38623918-B5310FB5-1EF8-4349-9010-9E738AEC9D00 Q38678543-E546D213-2E84-488D-9604-6889794AAEB4 Q38824324-838B87DC-5031-4580-81DB-F0CE85F89414 Q38844664-35238D39-AB14-4224-9EE9-53F1C155E9CA Q38915689-F9A93FDC-9CCF-4DF2-9D8D-0ED0064AE2C1 Q38997289-C6302BE5-7535-4113-8B0E-D71C7E85D939 Q39312802-03F11DEB-D47B-40C0-A078-B8D52FDEBA8A Q39587846-7D33DC1E-63E1-46F6-83A2-58E90DCDE53F

P2860

Reprimo as a potential biomarker for early detection in gastric cancer

http://www.wikidata.org/entity/Q28295727

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Reprimo as a potential biomarker for early detection in gastric cancer

@ast

Reprimo as a potential biomarker for early detection in gastric cancer

@en

Reprimo as a potential biomarker for early detection in gastric cancer

@nl

type

label

Reprimo as a potential biomarker for early detection in gastric cancer

@ast

Reprimo as a potential biomarker for early detection in gastric cancer

@en

Reprimo as a potential biomarker for early detection in gastric cancer

@nl

prefLabel

Reprimo as a potential biomarker for early detection in gastric cancer

@ast

Reprimo as a potential biomarker for early detection in gastric cancer

@en

Reprimo as a potential biomarker for early detection in gastric cancer

@nl

P1433

Q28295727-2A4AC394-18DD-4FA3-A7E4-66A13432ED7E

P1476

Q28295727-94E1C268-0A44-406E-AF89-CFC5990D6807

P2093

Q28295727-02F04DDA-3FDC-4BEC-A10B-B7B1DF12A21B

Q28295727-0B010A44-F398-49A3-B709-5CA971303103

Q28295727-2B272C31-24B4-4B6E-A1B4-77725CB819DF

Q28295727-3EBE6C86-F21C-4BEF-8354-10BCC0BB9A03

Q28295727-4866BD9D-060D-4E8E-ABAE-11E24C34424E

Q28295727-9C8732B2-3C49-48F2-BC24-6A2A1153129F

Q28295727-9E10C944-DC3F-485B-BAA9-E65028A71F6C

Q28295727-B19C8611-D453-451C-BCBB-561F337A586C

Q28295727-C1ACAD62-C072-4924-9BF9-B257ED495F6B

Q28295727-E58C05EE-BC74-40BE-ADCF-EF834D9CA35D

P304

Q28295727-68A6CE00-6E52-46B5-BCA1-778B0CC39535

P31

Q28295727-5D8B8B61-F6E4-43AC-B41C-A6C77AB3959A

P3181

Q28295727-2AC3EDF7-8089-4523-B2EA-330558F87732

P356

Q28295727-7EC0F30E-1A53-4426-8CAD-68858AC95ADB

P407

Q28295727-6EB5645F-8F5B-4E27-9577-494490AA1D1A

P433

Q28295727-76563EFA-4FDB-4DD1-9345-C6542409FC1E

P478

Q28295727-F34A9D41-DF58-4678-BD25-A0EFFF6F903A

P577

Q28295727-979B8A3D-90AB-49AB-A254-D1A499C5B6F2

P698

Q28295727-062C54DC-8B02-4989-A562-5E0FA3A341D1

P921

Q28295727-4A39D6AF-7B5A-4057-8013-AF6BC1356C2E

P3181

P356

1078-0432.CCR-07-4522

P1433

Clinical Cancer Research

P1476

Reprimo as a potential biomarker for early detection in gastric cancer

@en

P2093

Alejandro H Corvalan

http://www.w3.org/2001/XMLSchema#string

Carlos Barrientos

http://www.w3.org/2001/XMLSchema#string

Carolina Bernal

http://www.w3.org/2001/XMLSchema#string

Cynthia Villarroel

http://www.w3.org/2001/XMLSchema#string

Edmundo Aravena

http://www.w3.org/2001/XMLSchema#string

Eudocia Santibáñez

http://www.w3.org/2001/XMLSchema#string

Francisco Aguayo

http://www.w3.org/2001/XMLSchema#string

Francisco J Ossandon

http://www.w3.org/2001/XMLSchema#string

Ignacio Díaz

http://www.w3.org/2001/XMLSchema#string

Macarena Vargas

http://www.w3.org/2001/XMLSchema#string

P304

6264-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2996674

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1078-0432.CCR-07-4522

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18829507

http://www.w3.org/2001/XMLSchema#string

P921